ZYNE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ZYNE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Interest and Commission Paid only applicable to companies reporting Cash Flow from Operations in direct method.
Kenneth T Jones | officer: See Remarks | C/O ZYNERBA PHARMACEUITCALS, INC., 80 W. LANCASTER AVENUE, SUITE 300, DEVON PA 19333 |
Brian Rosenberger | officer: VP, Commercial & Business Dev. | C/O ZYNERBA PHARMACEUTICALS, INC., 80 WEST LANCASTER AVENUE, SUITE 300, DEVON PA 19333 |
Terri B Sebree | officer: President | ZYNERBA PHARMACEUTICALS, INC., 80 W. LANCASTER AVENUE, SUITE 300, DEVON PA 19333 |
James E Fickenscher | officer: Chief Financial Officer | C/O AUXILIUM PHARMACEUTICALS, INC., 640 LEE ROAD, CHESTERBROOK PA 19087 |
Armando Anido | director, officer: Chairman & Chief Exec. Officer | 80 W. LANCASTER AVENUE, SUITE 300, DEVON PA 19333 |
Kenneth I Moch | director | 68 WILLOW AVE, LARCHMONT NY 10538 |
Warren D Cooper | director | NUTRITION 21 INC, 4 MANHATTANVILLE ROAD, PURCHASE NY 10577 |
Pamela Stephenson | director | C/O ZYNERBA PHARMACEUTICALS, INC., 80 W. LANCASTER AVENUE, SUITE 300, DEVON PA 19333 |
John P. Butler | director | C/O RELYPSA, INC., 700 SAGINAW DR., REDWOOD CITY CA 94063 |
Daniel L Kisner | director | 2292 FARADAY AVENUE, CARLSBAD CA 92008 |
William J Federici | director | 530 HERMAN O. WEST DRIVE, EXTON PA 19341 |
Albert P Parker | officer: Chief Legal Officer | C/O ONCOCYTE CORPORATION, 1010 ATLANTIC AVENUE, SUITE 102, ALAMEDA CA 94501 |
Suzanne M. Hanlon | officer: Sec, General Counsel & VP HR | 80 W. LANCASTER AVENUE, SUITE 300, DEVON PA 19333 |
Michael Rapp | 10 percent owner | 712 FIFTH AVENUE, 49TH FLOOR, NEW YORK NY 10019 |
Thomas L Harrison | director |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.